CANNAPHARMARX, INC. (CPMD) stock: key figures, P/E, revenue and dividend
Health Care · Canada · ISIN US13765D1090
Price
0.00 USD
Market cap
1.42 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
CANNAPHARMARX, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 1.36 m USD |
| Gross profit | -2.08 m USD |
| Operating income | -3.35 m USD |
| EBIT | -9.17 m USD |
| Net income | -11.13 m USD |
| Diluted EPS – continuing operations | -0.02 USD |
Full history since 1998, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About CANNAPHARMARX, INC.
CannaPharmaRX, Inc. engages in acquisition, development, and operation of cannabis cultivation facilities in Germany, Israel, Portugal, and Canada. It produces and sells dried cannabis flower and trim shake, as well as unique genetics, medical cannabis, and craft products. The company is based in Cremona, Canada.
More stocks
- Tego Cyber, Inc. (TGCB)
- GLOBAL TECHNOLOGIES LTD (GTLL)
- VYCOR MEDICAL INC (VYCO)
- Ranger Gold Corp. (RNGC)
- Cleartronic, Inc. (CLRI)
- NUTRA PHARMA CORP (NPHC)
- Pony Group Inc. (PNYG)
- FUSE GROUP HOLDING INC. (FUST)
- Artisan Consumer Goods, Inc. (ARRT)
- Aphoenity International Holdings Inc. (LDSN)
- Greentech Innovations, Inc. (GTIC)
- IP STRATEGY HOLDINGS, INC. (IPST)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.